Back
Lantern Pharma Stock Predictions
Buy
66
LTRN
Lantern Pharma
Last Price:
6.13
Seasonality Move:
0.01%
7 Day Trial
ALL ACCESS PASS
$
7
Lantern Pharma Stock Forecast
- Over the next 52 weeks, Lantern Pharma has on average historically fallen by 16.3% based on the past 3 years of stock performance.
- Lantern Pharma has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Lantern Pharma Stock Undervalued?
The current Lantern Pharma [LTRN] share price is $6.03. The Score for LTRN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal. - LTRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Lantern Pharma Stock Go Up Next Year?
- Over the next 52 weeks, Lantern Pharma has on average historically fallen by 16.3% based on the past 3 years of stock performance.
Lantern Pharma Stock Rating
Buy
66
Lantern Pharma (LTRN)
is a Buy
Is Lantern Pharma overpriced?
- Lantern Pharma has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Lantern Pharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lanternpharma.com
52-Week Data
52-Week High:
11.99
52-Week Low:
2.38
Prediction Charts
Market Cap:
64.88M
Price in USD:
6.03
Volume:
43.84K
Beta:
1.61
Technical Analysis
SMA50:
7.12
SMA100:
5.68
SMA200:
4.76
52-Wk Change:
23.06%
Stock Predictions
-
Is Lantern Pharma stock public?
Yes, Lantern Pharma is a publicly traded company. -
What is the Lantern Pharma stock quote today?
The Lantern Pharma stock price is 6.03 USD today. -
How to buy Lantern Pharma stock online?
You can buy Lantern Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 4.90 | 5.09 | 5.36 | 4.90 |
| May-1 | 5.29 | 5.33 | 5.68 | 5.21 |
| May-2 | 5.58 | 5.44 | 5.60 | 5.27 |
| May-3 | 5.57 | 6.15 | 6.37 | 5.57 |
| May-6 | 6.30 | 6.90 | 7.21 | 6.24 |
| May-7 | 6.90 | 6.42 | 7.02 | 6.23 |
| May-8 | 6.52 | 6.48 | 6.82 | 6.20 |
| May-9 | 6.38 | 6.81 | 7.01 | 6.34 |
| May-10 | 6.15 | 6.16 | 6.81 | 5.79 |
| May-13 | 6.18 | 6.09 | 6.55 | 6.09 |
| May-14 | 6.18 | 6.19 | 6.45 | 6.08 |
| May-15 | 6.47 | 6.33 | 6.58 | 6.03 |
| May-16 | 6.28 | 6.14 | 6.49 | 6.06 |
| May-17 | 6.11 | 6.03 | 6.33 | 5.90 |
Lantern Pharma Earnings
Lantern Pharma Earnings Report: Per Share Lantern Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.
Lantern Pharma Forecast Revenue Growth
Lantern Pharma Stock Analysis: Historical quarterly revenues per share for Lantern Pharma and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and an increase next year of $0.52 per share.
* Lantern Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.